An Open-Label, Dose-Ranging Study Followed by a Double-BLind Placebo Controlled Study of CVT-510 Administered as a Bolus Loading Dose and Titratable Infusion in Patients with Rapid Atrial Fibrillation or Flutter

  • Mentzer, Robert (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date9/1/019/1/01